Biallelic variants in RABGAP1, the GTPase‐activating protein of RAB6A for retrograde transport from Golgi to ER, were reported in patients with global developmental delay, microcephaly, bilateral sensorineural hearing loss, seizures, corpus callosum dysgenesis, and facial dysmorphism. Here, RABGAP1 is linked to microcephaly.